XBIOTECH INC. (XBIT) Return on equity 2018–2023
XBIOTECH INC. (XBIT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-11.2%FY2023 · since FY2018: -51.1% → -11.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -11.2% | +2.5 pp |
| FY2022 | -13.7% | -7.2 pp |
| FY2021 | -6.5% | -3.2 pp |
| FY2020 | -3.2% | -91.7 pp |
| FY2019 | 88.5% | +139.5 pp |
| FY2018 | -51.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice